Literature DB >> 29135770

An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.

Jessica Chubak1, Tracy Onega, Weiwei Zhu, Diana S M Buist, Rebecca A Hubbard.   

Abstract

OBJECTIVES: Studies of cancer recurrences and second primary tumors require information on outcome dates. Little is known about how well electronic health record-based algorithms can identify dates or how errors in dates can bias analyses. RESEARCH
DESIGN: We assessed rule-based and model-fitting approaches to assign event dates using a previously published electronic health record-based algorithm for second breast cancer events (SBCE). We conducted a simulation study to assess bias due to date assignment errors in time-to-event analyses.
SUBJECTS: From a cohort of 3152 early-stage breast cancer patients, 358 women accurately identified as having had an SBCE served as the basis for this analysis. MEASURES: Percent of predicted SBCE dates identified within ±60 days of the true date was the primary measure of accuracy. In the simulation study, bias in hazard ratios (HRs) was estimated by averaging the difference between HRs based on algorithm-assigned dates and the true HR across 1000 simulations each with simulated N=4000.
RESULTS: The most accurate date algorithm had a median difference between the true and predicted dates of 0 days with 82% of predicted dates falling within 60 days of the true date. Bias resulted when algorithm sensitivity and specificity varied by exposure status, but was minimal when date assignment errors were of the magnitude observed for our date assignment method.
CONCLUSIONS: SBCE date can be relatively accurately assigned based on a previous algorithm. While acceptable in many scenarios, algorithm-assigned dates are not appropriate to use when operating characteristics are likely to vary by the study exposure.

Entities:  

Mesh:

Year:  2017        PMID: 29135770      PMCID: PMC4592686          DOI: 10.1097/MLR.0000000000000352

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  Tradeoffs between accuracy measures for electronic health care data algorithms.

Authors:  Jessica Chubak; Gaia Pocobelli; Noel S Weiss
Journal:  J Clin Epidemiol       Date:  2011-12-23       Impact factor: 6.437

2.  Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer.

Authors:  Jessica Chubak; Onchee Yu; Gaia Pocobelli; Lois Lamerato; Joe Webster; Marianne N Prout; Marianne Ulcickas Yood; William E Barlow; Diana S M Buist
Journal:  J Natl Cancer Inst       Date:  2012-04-30       Impact factor: 13.506

3.  Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.

Authors:  Michael J Hassett; Debra P Ritzwoller; Nathan Taback; Nikki Carroll; Angel M Cronin; Gladys V Ting; Deb Schrag; Joan L Warren; Mark C Hornbrook; Jane C Weeks
Journal:  Med Care       Date:  2014-10       Impact factor: 2.983

4.  Identifying cancer relapse using SEER-Medicare data.

Authors:  Craig C Earle; Ann B Nattinger; Arnold L Potosky; Kathleen Lang; Rajiv Mallick; Mark Berger; Joan L Warren
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

5.  Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry.

Authors:  Donna McClish; Lynne Penberthy; Amy Pugh
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

6.  Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients.

Authors:  Joan L Warren; Angela Mariotto; Danielle Melbert; Deborah Schrag; Paul Doria-Rose; David Penson; K Robin Yabroff
Journal:  Med Care       Date:  2016-08       Impact factor: 2.983

7.  Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).

Authors:  Elizabeth B Lamont; James E Herndon; Jane C Weeks; I Craig Henderson; Craig C Earle; Richard L Schilsky; Nicholas A Christakis
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

  7 in total
  10 in total

1.  Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.

Authors:  Lu Chen; Jessica Chubak; Denise M Boudreau; William E Barlow; Noel S Weiss; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08-14       Impact factor: 4.254

2.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

3.  A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data.

Authors:  Hava Izci; Tim Tambuyzer; Krizia Tuand; Victoria Depoorter; Annouschka Laenen; Hans Wildiers; Ignace Vergote; Liesbet Van Eycken; Harlinde De Schutter; Freija Verdoodt; Patrick Neven
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

4.  Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data.

Authors:  Hajime Uno; Debra P Ritzwoller; Angel M Cronin; Nikki M Carroll; Mark C Hornbrook; Michael J Hassett
Journal:  JCO Clin Cancer Inform       Date:  2018-12

5.  Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.

Authors:  Debra P Ritzwoller; Michael J Hassett; Hajime Uno; Angel M Cronin; Nikki M Carroll; Mark C Hornbrook; Lawrence C Kushi
Journal:  J Natl Cancer Inst       Date:  2018-03-01       Impact factor: 13.506

6.  Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.

Authors:  Lu Chen; Jessica Chubak; Denise M Boudreau; William E Barlow; Noel S Weiss; Christopher I Li
Journal:  Cancer Res       Date:  2017-09-21       Impact factor: 12.701

7.  Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk; Lene Mellemkjær; Søren Friis; Trine Tramm; Mette Nørgaard; Deirdre P Cronin-Fenton
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

8.  Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence.

Authors:  Yong Chen; Jianqiao Wang; Jessica Chubak; Rebecca A Hubbard
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-10-30       Impact factor: 2.890

9.  New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.

Authors:  Hyunmin Jung; Mingshan Lu; May Lynn Quan; Winson Y Cheung; Shiying Kong; Sasha Lupichuk; Yuanchao Feng; Yuan Xu
Journal:  BMC Cancer       Date:  2022-03-16       Impact factor: 4.430

10.  Treatment and Monitoring Variability in US Metastatic Breast Cancer Care.

Authors:  Jennifer L Caswell-Jin; Alison Callahan; Natasha Purington; Summer S Han; Haruka Itakura; Esther M John; Douglas W Blayney; George W Sledge; Nigam H Shah; Allison W Kurian
Journal:  JCO Clin Cancer Inform       Date:  2021-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.